Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure | Clinical Trials | Clareo Health

Back to search

TERMINATEDPhase 2

Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure

NCT02864316•Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Solid Tumors Induced by Prior Radiation Exposure

Interventions

Nivolumab

Locations

United States

Locations (1)

Sidney Kimmel Cancer Center @ Johns Hopkins

Baltimore, Maryland, United States

Key Dates

Start Date

December 1, 2016

Primary Completion Date

August 1, 2018

Completion Date

September 1, 2018

Last Updated

August 28, 2019

Sponsors

Lead Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

Bristol-Myers Squibb

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions